What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cytokine
Yoshinori Fukui focuses on Cell biology, Dock2, Lymphocyte, Motility and B cell.
His Cell biology research incorporates themes from Acquired immune system, Immunology and Cytoskeleton.
His studies deal with areas such as ELMO1, Phosphoinositide 3-kinase, Chemotaxis, Actin and Rac GTP-Binding Proteins as well as Dock2.
His work carried out in the field of Phosphoinositide 3-kinase brings together such families of science as Lymphocyte homing receptor, Synapse, Integrin and Immunological Synapses.
His studies in Lymphocyte integrate themes in fields like Chemokine, T cell and Actin cytoskeleton.
His Motility research focuses on RAC1 and how it connects with Chimera, Secretion and Microbiology.
His most cited work include:
- Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration (387 citations)
- Neutrophils scan for activated platelets to initiate inflammation (330 citations)
- Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis. (222 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Cell biology, Dock2, Immunology, Guanine nucleotide exchange factor and Molecular biology.
Yoshinori Fukui has researched Cell biology in several fields, including Chemokine, Immune system and Lymphocyte.
His study looks at the intersection of Chemokine and topics like Integrin with Actin remodeling and Lamellipodium.
The study incorporates disciplines such as Lymphocyte homing receptor and B cell in addition to Lymphocyte.
His Dock2 research includes elements of ELMO1, Chemotaxis, Actin cytoskeleton, Motility and Actin.
His Molecular biology research incorporates elements of T cell, T-cell receptor, CD8, Cytotoxic T cell and Major histocompatibility complex.
He most often published in these fields:
- Cell biology (59.29%)
- Dock2 (38.57%)
- Immunology (17.86%)
What were the highlights of his more recent work (between 2013-2021)?
- Cell biology (59.29%)
- Dock2 (38.57%)
- Guanine nucleotide exchange factor (15.00%)
In recent papers he was focusing on the following fields of study:
Cell biology, Dock2, Guanine nucleotide exchange factor, Signal transduction and Inflammation are his primary areas of study.
His specific area of interest is Cell biology, where Yoshinori Fukui studies Microtubule.
His biological study spans a wide range of topics, including Cd4 t cell, Chemotaxis, Actin cytoskeleton, Small GTPase and Lymph.
Within one scientific family, Yoshinori Fukui focuses on topics pertaining to Rac GTP-Binding Proteins under Guanine nucleotide exchange factor, and may sometimes address concerns connected to HEK 293 cells, Receptor tyrosine kinase and AXL receptor tyrosine kinase.
His study looks at the relationship between Signal transduction and topics such as Immunoglobulin E, which overlap with Degranulation.
While the research belongs to areas of Inflammation, Yoshinori Fukui spends his time largely on the problem of Receptor, intersecting his research to questions surrounding Metabolism and Mitochondrion.
Between 2013 and 2021, his most popular works were:
- Neutrophils scan for activated platelets to initiate inflammation (330 citations)
- A functional genomics predictive network model identifies regulators of inflammatory bowel disease. (90 citations)
- Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis. (90 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cytokine
Yoshinori Fukui spends much of his time researching Cell biology, Signal transduction, Guanine nucleotide exchange factor, Immunology and Dock5.
His Cell biology research includes themes of Dendritic cell, Dock2, Cell growth and Cellular differentiation.
The concepts of his Dock2 study are interwoven with issues in Actin cytoskeleton and Small GTPase.
Yoshinori Fukui works mostly in the field of Signal transduction, limiting it down to concerns involving Immunoglobulin E and, occasionally, EPAS1 and Degranulation.
His Immunology research integrates issues from Dermatology and Receptor.
His research integrates issues of Cancer cell, Glutamine and Microtubule in his study of Dock5.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
